Platform for fast (rt-)qpcr
The platform system combines a microfluidic disposable cartridge with a compact analyzer to deliver highly time‑efficient thermocycling via oscillating fluidics. Integrated pre‑analytics and on‑chip reagent preloading can minimize hands‑on steps and reduce contamination risk, while hybrid operation supports semi‑ or fully automated workflows, including integration with collaborative robots for loading and handling. This shortens turnaround times, increases throughput and reproducibility, and enables scalable deployment from central laboratories to decentralized settings. Proof to date includes completed clinical evaluation for SARS‑CoV‑2 detection. Next steps focus on expanding the assay portfolio beyond respiratory targets, deepening automation and workflow integration, scaling manufacturing, conducting usability and robustness studies in routine environments, and preparing regulatory submissions.
About Fraunhofer Institute
Fraunhofer is a large, multi-site applied research organization based in Germany, operating a nationwide network of institutes and research units with a strong industry-facing mission. Its contract-research model aligns work to real manufacturing and deployment needs, with pilot lines, test labs, and demonstration facilities for validation and scale-up. Many institutes are integrated with nearby universities and regional industry clusters, enabling joint appointments, shared infrastructure, and fast talent pipelines. Research is supported by competitive European programs alongside German federal and state funding, complemented by extensive contract revenue from private-sector collaborations. A dedicated technology transfer function manages IP, licensing, and startup formation.
delivered to your inbox.